Clinical Trial Update: Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer [Phase 2]

View source ↗

Summary

Phase II randomized trial comparing baby exemestane to baby tamoxifen in post-menopausal women at high risk for breast cancer (not yet recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Lobular Hyperplasia
• Breast Cancer
• Ductal Carcinoma of the Breast
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Baby Exemestane (exemestane)
• Baby Tamoxifen (tamoxifen)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Ductal Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING